Free Trial

Harmony Biosciences (HRMY) SEC Filings & 10K Form

Harmony Biosciences logo
$32.09 -0.02 (-0.06%)
Closing price 03:51 PM Eastern
Extended Trading
$32.18 +0.09 (+0.28%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Harmony Biosciences SEC Filings

DateFilerForm TypeView
06/11/2025
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2025
7:30 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:15 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
7:00 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2025
1:47 PM
BlackRock, Inc. (Filed by)
Harmony Biosciences (Subject)
Form SCHEDULE 13G/A
04/04/2025
4:51 PM
Harmony Biosciences (Issuer)
Philip Ron M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/04/2025
4:52 PM
Harmony Biosciences (Issuer)
Philip Ron M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
3:17 PM
Harmony Biosciences (Filer)
Form DEF 14A
04/04/2025
3:19 PM
Harmony Biosciences (Filer)
Form DEFA14A
04/04/2025
3:20 PM
Harmony Biosciences (Filer)
Form ARS
04/03/2025
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
3:27 PM
Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/24/2025
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
7:00 AM
Harmony Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
5:10 PM
Harmony Biosciences (Subject)
Valor IV Pharma Holdings, LLC (Filed by)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM
BlackRock, Inc. (Filed by)
Harmony Biosciences (Subject)
Form SCHEDULE 13G/A
01/30/2025
8:57 PM
Harmony Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/28/2025
11:51 AM
Harmony Biosciences (Issuer)
Serafin Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:27 PM
Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:27 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2025
3:18 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
3:17 PM
Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:15 PM
Harmony Biosciences (Issuer)
Kapadia Sandip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
7:44 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2025
3:20 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:21 PM
Dayno Jeffrey M. (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/21/2025
3:21 PM
Harmony Biosciences (Subject)
Kapadia Sandip (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
3:30 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
3:30 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
3:26 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
7:15 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:48 PM
Gracias Antonio J. (Reporting)
Harmony Biosciences (Issuer)
Sabater Juan A. (Reporting)
Valor Equity Associates IV L.P. (Reporting)
Valor Equity Capital IV LLC (Reporting)
VALOR EQUITY PARTNERS IV L.P. (Reporting)
VALOR EQUITY PARTNERS IV-A L.P. (Reporting)
VALOR EQUITY PARTNERS IV-B L.P. (Reporting)
Valor IV Pharma Holdings, LLC (Reporting)
Valor Management L.P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:05 PM
Harmony Biosciences (Issuer)
Marshman Fund Trust II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:06 PM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
3:39 PM
Harmony Biosciences (Filer)
Form 424B7
10/31/2024
3:45 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2024
4:27 PM
Harmony Biosciences (Filer)
Form 424B7
10/29/2024
3:22 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
6:50 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This Signal Only Flashes Once Every 4 Years – And It Just Triggered (Ad)

This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.

Missed the Last Crypto Boom? Don’t Miss This One - PLUS Claim your $10 in Bitcoin
10/03/2024
3:32 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
3:35 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/01/2024
7:45 AM
Harmony Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
3:28 PM
Dierks Jeffrey (Reporting)
Harmony Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
7:00 AM
Harmony Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HRMY) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners